Metabolomic Diagnostics to attend SRI, Paris

February 26th, 2019|0 Comments

Metabolomic Diagnostics’ CEO, Mr Charles Garvey and VP of R&D, Dr Robin Tuytten, PhD, will attend the 66th Annual Meeting of the Society for Reproductive Investigations (SRI) in Paris, France. “From Innovation to Impact” is [...]

Metabolomic Diagnostics appoints Marketing Manager

February 26th, 2019|0 Comments

We are pleased to announce the appointment of Mrs AnnMarie Barrett to the position of Marketing Manager at Metabolomic Diagnostics. Mrs Barrett is an experienced commercial executive with over 20 years in the life science/biotechnology [...]

Metabolomic Diagnostics appoints Scientific Researcher and Writer

January 20th, 2019|0 Comments

We are pleased to announce the appointment of Dr Carmen Romera to the position of Scientific Writer and Researcher at Metabolomic Diagnostics. Dr Romera graduated from University Autonoma of Barcelona in Spain with a degree [...]

Metabolomic Diagnostics to Present at OPERA Europe Workshop

November 18th, 2018|0 Comments

The 2018 Optimal Pregnancy Environment Risk Assessment (OPERA) Europe Workshop will take place in Pforzheim, Germany and Metabolomic Diagnostics will present at the event. OPERA is an international interdisciplinary program of researchers, care providers, foundations [...]

Metabolomic Diagnostics to present poster at ISSHP

September 15th, 2018|0 Comments

The 2018 Congress of the International Society of Hypertension in Pregnancy will take place in Amsterdam this year and Metabolomic Diagnostics will sponsor and present a poster at the event.  It will be a joint [...]

Metabolomic Diagnostics is Expanding and Recruiting

July 4th, 2018|0 Comments

As part of our expansion plans, here at our headquarters in Little Island, Co Cork, we are currently recruiting in several key areas of the business. We have open vacancies in our Research and Quality [...]

  • EU Flag

METABOLOMIC DIAGNOSTICS SECURES €2 MILLION IN EU FUNDING

May 15th, 2018|0 Comments

Cork & Dublin, 15 May 2018: Having been ranked among the top innovations in Europe, Metabolomic Diagnostics is set to receive €2 million in EU Funding under the Horizon 2020 SME Instrument, which received a [...]

Novel method for interrogating receiver operating characteristic curves for prognostic tests

November 23rd, 2017|0 Comments

Disease prevalence is rarely explicitly considered in the early stages of the development of novel prognostic tests. Rather, researchers use the area under the receiver operating characteristic (AUROC) as the keymetric to gauge and report [...]

Prof. Louise Kenny, Founding Director, wins Women Mean Business in Technology Award

October 23rd, 2017|0 Comments

Metabolomic Diagnostics wins Women Mean Business Woman In Technology Award WMB held its 11th annual Women Mean Business Conference & Awards in Dublin’s Shelbourne Hotel on the 2nd of October last. The event recognises the [...]

Robin Tuytten serves on Advisory Board of HUPO 2017

October 18th, 2017|0 Comments

Robin Tuytten, Metabolomic Diagnostics VP Research and Development serves on the Advisory Board of HUPO 2017 the 16th Annual World Congress of the Human Proteome Organisation which will be held in Dublin on 17-21st September [...]